{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T15:52:49Z","timestamp":1762271569937,"version":"3.38.0"},"publisher-location":"Boston, MA","reference-count":41,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781461374398"},{"type":"electronic","value":"9781461553472"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998]]},"DOI":"10.1007\/978-1-4615-5347-2_19","type":"book-chapter","created":{"date-parts":[[2011,8,12]],"date-time":"2011-08-12T23:25:18Z","timestamp":1313191518000},"page":"177-182","source":"Crossref","is-referenced-by-count":4,"title":["Immunomodulation Mediated by Microinjection of Morphine into the Periaqueductal Gray Matter of the Mesencephalon"],"prefix":"10.1007","author":[{"given":"Jin-Liang","family":"Suo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"19_CR1","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0022-3565(25)39466-8","volume":"267","author":"I Szabo","year":"1993","unstructured":"Szabo, I., M. Rojavin, J. L. Bussiere, T. K. Eisenstein, M. W. Adler, and T. J. Rogers. 1993. Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids. J Pharmacol Exp Ther 267: 703.","journal-title":"J Pharmacol Exp Ther"},{"key":"19_CR2","first-page":"341","volume":"76","author":"RJ Weber","year":"1987","unstructured":"Weber, R. J., B. Ikejiri, K. C. Rice, A. Pert, and A. A. Hagan. 1987. Opiate receptor mediated regulation of the immune response in vivo. NIDA Res Monogr 76: 341.","journal-title":"NIDA Res Monogr"},{"key":"19_CR3","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1126\/science.2749256","volume":"245","author":"RJ Weber","year":"1989","unstructured":"Weber, R. J. and A. Pert. 1989. The periaqueductal gray matter mediates opiate-induced immunosuppression. Science 245: 188.","journal-title":"Science"},{"key":"19_CR4","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/0028-3908(90)90096-A","volume":"29","author":"BM Bayer","year":"1990","unstructured":"Bayer, B. M., S. Daussin, M. Hernandez, and L. Irvin. 1990. Morphine inhibition of lymphocyte activity is mediated by an opioid dependent mechanism. Neumpharmacology 29: 369.","journal-title":"Neumpharmacology"},{"key":"19_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0165-2478(90)90026-M","volume":"24","author":"RN Apte","year":"1990","unstructured":"Apte, R. N., S. K. Durum, and J. J. Oppenheim. 1990. Opioids modulate interleukin-1 production and secretion by bone-marrow macrophages. Immunol. Lett. 24: 141.","journal-title":"Immunol. Lett."},{"key":"19_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1006\/cimm.1994.1061","volume":"154","author":"P Bergh van den","year":"1994","unstructured":"van den Bergh, P., R. Dobber, S. Ramlal, J. Rozing, and L. Nagelkerken. 1994. Role of opioid peptides in the regulation of cytokine production by murine CD4+ T cells. Cell Immunol. 154: 109.","journal-title":"Cell Immunol."},{"key":"19_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4615-1951-5_1","volume":"373","author":"S Matta","year":"1995","unstructured":"Matta, S., D. Saphier, D. Lysle, and B. Sharp. 1995. The brain-immune axis: role of opiates and other substances of abuse, the hypothalamic-pituitary-adrenal axis and behavior. Adv. Exp. Med. Biol. 373: 1.","journal-title":"Adv. Exp. Med. Biol."},{"key":"19_CR8","doi-asserted-by":"publisher","first-page":"7114","DOI":"10.1073\/pnas.83.18.7114","volume":"83","author":"Y Shavit","year":"1986","unstructured":"Shavit, Y., A. Depaulis, F. C. Martin, G. W. Terman, R. N. Pechnick, C. J. Zane, R. P. Gale, and J. C. Liebeskind. 1986. Involvement of brain opiate receptors in the immune-suppressive effect of morphine. Proc. Natl. Acad. Sci. U. S. A. 83: 7114.","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"19_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/978-1-4615-1951-5_21","volume":"373","author":"KE Hoffman","year":"1995","unstructured":"Hoffman, K. E., K. A. Maslonek, L. A. Dykstra, and D. T. Lysle. 1995. Effects of central administration of morphine on immune status in Lewis and Wistar rats. Adv. Exp. Med. Biol. 373: 155.","journal-title":"Adv. Exp. Med. Biol."},{"key":"19_CR10","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0022-3565(25)39585-6","volume":"267","author":"MC Hernandez","year":"1993","unstructured":"Hernandez, M. C., L. R. Flores, and B. M. Bayer. 1993. Immunosuppression by morphine is mediated by central pathways Immunosuppression by morphine is mediated by central pathways. J Pharmacol Exp Ther 267: 1336.","journal-title":"J Pharmacol Exp Ther"},{"key":"19_CR11","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0022-3565(25)12317-3","volume":"276","author":"K Fecho","year":"1996","unstructured":"Fecho, K., K. A. Maslonek, L. A. Dykstra, and D. T. Lysle. 1996. Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats. J Pharmacol Exp Ther 276: 626.","journal-title":"J Pharmacol Exp Ther"},{"key":"19_CR12","first-page":"95","volume":"5","author":"LC Band","year":"1992","unstructured":"Band, L. C., A. Pert, W. Williams, B. R. de Costa, K. C. Rice, and R. J. Weber. 1992. Central u-Opioid Receptors Mediate Suppression of Natural Killer Activity in vivo. Progress in Neuroendocrinimmunology 5: 95.","journal-title":"Progress in Neuroendocrinimmunology"},{"key":"19_CR13","first-page":"330","volume":"119","author":"LC Band","year":"1992","unstructured":"Band, L. C., A. Pert, W. Wiliams, M. Seggel, B. R. Decosta, D. Thomasson, K. C. Rice, and R. J. Weber. 1992. Delineation of Central Opioid Receptors Regulating Natural Killer Cell Activity In Vivo. NIDA Res Monogr 119: 330.(Abstract)","journal-title":"NIDA Res Monogr"},{"key":"19_CR14","volume-title":"Encyclopedia of neuroscience","author":"RJ Weber","year":"1996","unstructured":"Weber, R. J. and A. Pert. 1996. Immune system: Neural control. In Encyclopedia of neuroscience. B. Smith and G. Adelman, eds. Birkhauser Boston, Cambridge, MA."},{"key":"19_CR15","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/0301-0082(95)00009-K","volume":"46","author":"MM Behbehani","year":"1995","unstructured":"Behbehani, M. M. 1995. Functional characteristics of the midbrain periaqueductal gray. Prog Neurobiol 46: 575.","journal-title":"Prog Neurobiol"},{"key":"19_CR16","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0022-3565(25)13105-4","volume":"277","author":"DT Lysle","year":"1996","unstructured":"Lysle, D. T., K. E. Hoffman, and L. A. Dykstra. 1996. Evidence for the involvement of the caudal region of the periaqueductal gray in a subset of morphine-induced alterations of immune status. J Pharmacol Exp Ther 277: 1533.","journal-title":"J Pharmacol Exp Ther"},{"key":"19_CR17","first-page":"121","volume":"16","author":"TH Bian","year":"1995","unstructured":"Bian, T. H. and X. Y. Li. 1995. Immunomodulating effects of morphine microinjected into periaqueductal gray. Chung. Kuo. Yao. Li. Hsueh. Pao. 16: 121.","journal-title":"Chung. Kuo. Yao. Li. Hsueh. Pao."},{"key":"19_CR18","first-page":"150","volume":"59","author":"JL Suo","year":"1997","unstructured":"Suo, J.-L. and R. J. Weber. 1997. Immunosuppression following PAG morphine is correlated with activation of the HPA axis and is not blocked by mifepristone. College for the Problems of Drug Dependence Submitted 59: 150. (Abstract)","journal-title":"College for the Problems of Drug Dependence Submitted"},{"key":"19_CR19","first-page":"54","volume":"59","author":"R Gomez-Florez","year":"1997","unstructured":"Gomez-Florez, R. and R. J. Weber. 1997. Effect of acute morphine injection in th eperiaqueductal gray matter on macrophage fonctions. College for the Problems of Drug Dependence Submitted 59: 54. (Abstract)","journal-title":"College for the Problems of Drug Dependence Submitted"},{"key":"19_CR20","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/0028-3908(78)90012-6","volume":"17","author":"WK Ho","year":"1978","unstructured":"Ho, W. K., S. Lam, K. C. Leung, K. K. Au, H. K. Wong, Y. F. Tsang, and H. L. Wen. 1978. Effect of naloxone on morphine-induced changes in ACTH, corticosterone and cyclic nucleotides. Neuropharmacology 17: 397.","journal-title":"Neuropharmacology"},{"key":"19_CR21","first-page":"260","volume":"10","author":"R George","year":"1955","unstructured":"George, R. and E. L. Way. 1955. Studies on the mechanism of pituitary-adrenal activation by morphine. Br J Pharm Chem 10: 260.","journal-title":"Br J Pharm Chem"},{"key":"19_CR22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-3565(25)12961-3","volume":"125","author":"R George","year":"1959","unstructured":"George, R. and E. L. Way. 1959. The role of the hypothalamus in pituitary-adrenal activation by morphine. J Pharmacol Exp Ther 125: 111.","journal-title":"J Pharmacol Exp Ther"},{"key":"19_CR23","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/0006-2952(88)90150-5","volume":"37","author":"Y Shavit","year":"1988","unstructured":"Shavit, Y., A. Depaulis, F. C. Martin, G. W. Terman, R. N. Pechnick, C. J. Zane, R. P. Gale, A. Simonya, B. Kanyicska, T. Szetendrei, and M. Fekete. 1988. Effect of chronic morphine treatment on the adrenaline biosynthesis in adrenals and brain regions of the rat. Biochem Pharmacol 37: 749.","journal-title":"Biochem Pharmacol"},{"key":"19_CR24","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/0006-8993(89)91122-0","volume":"498","author":"KE Nikolarakis","year":"1989","unstructured":"Nikolarakis, K. E., A. Pfeiffer, G. K. Stalla, and A. Herz. 1989. Facilitation of ACTH secretion by morphine is mediated by activation of CRF releasing neurons and sympathetic neuronal pathways. Brain Res 498: 385.","journal-title":"Brain Res"},{"key":"19_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1159\/000123364","volume":"35","author":"JC Buckingham","year":"1982","unstructured":"Buckingham, J. C. 1982. Secretion of corticotrophin and its hypothalamic releasing factor in response to morphine and opioid peptides. Neuroendocrinology. 35: 111.","journal-title":"Neuroendocrinology"},{"key":"19_CR26","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1016\/0006-2952(67)90012-3","volume":"16","author":"O Nikodijevic","year":"1967","unstructured":"Nikodijevic, O. and R. P. Maickel. 1967. Some effects of morphine on pituitary-adrenocortical function in the rat. Biochem Pharmacol 16: 2137.","journal-title":"Biochem Pharmacol"},{"key":"19_CR27","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0165-5728(96)00178-6","volume":"72","author":"K Karalis","year":"1997","unstructured":"Karalis, K., L. J. Muglia, D. Bae, H. Hilderbrand, and J. A. Majzoub. 1997. CRH and the immune system. J Neuroimmunol 72: 131.","journal-title":"J Neuroimmunol"},{"key":"19_CR28","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0022-3565(25)22517-4","volume":"270","author":"DO Freier","year":"1994","unstructured":"Freier, D. O. and B. A. Fuchs. 1994. A mechanism of action for morphine-induced immunosuppression: corticosterone mediates morphine-induced suppression of natural killer cell activity. J Pharmacol Exp Ther 270: 1127.","journal-title":"J Pharmacol Exp Ther"},{"key":"19_CR29","first-page":"77","volume":"27","author":"L Matera","year":"1988","unstructured":"Matera, L., E. Cardoso, F. Veglia, A. Cesano, G. Bellone, A. Vuolo, and G. M. Molinatti. 1988. Effect of cortisol on the native and in vitro induced non-MHC restricted eytotoxicity of large granular lymphocytes. J. Clin. Lab. Immunol. 27: 77.","journal-title":"J. Clin. Lab. Immunol."},{"key":"19_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0022-4731(87)90030-6","volume":"26","author":"G Gatti","year":"1987","unstructured":"Gatti, G., R. Cavallo, M. L. Sartori, D. del Ponte, R. Masera, A. Salvadori, R. Carignola, and A. Angeli. 1987. Inhibition by cortisol of human natural killer (NK) cell activity. J. Steroid Biochem. 26: 49.","journal-title":"J. Steroid Biochem."},{"key":"19_CR31","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/j.1398-9995.1986.tb00303.x","volume":"41","author":"BK Pedersen","year":"1986","unstructured":"Pedersen, B. K. and J. M. Beyer. 1986. Characterization of the in vitro effects of glucocorticosteroids on NK cell activity. Allergy 41: 220.","journal-title":"Allergy"},{"key":"19_CR32","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3181\/00379727-171-41489","volume":"171","author":"WI Cox","year":"1982","unstructured":"Cox, W. I., N. J. Holbrook, R. J. Grasso, S. Specter, and H. Friedman. 1982. Suppression of the natural killer cell activity of murine spleen cell cultures by dexamethasone (41489). Proc Soc Exp Biol hied 171: 146.","journal-title":"Proc Soc Exp Biol hied"},{"key":"19_CR33","first-page":"273","volume":"325","author":"BM Bayer","year":"1990","unstructured":"Bayer, B. M., M. Hernandez, and L. Irvin. 1990. Suppression of lymphocyte activity after acute morphine administration appears to be glucocorticoid independent. Alcohol, Immunomodulation, and AIDS 325: 273.","journal-title":"Alcohol, Immunomodulation, and AIDS"},{"key":"19_CR34","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0165-5728(94)90064-7","volume":"53","author":"DJ Carr","year":"1994","unstructured":"Carr, D. J., S. Mayo, B. M. Gebhardt, and J. Porter. 1994. Central alpha-adrenergic involvement in morphine-mediated suppression of splenic natural killer activity. J Neuroimmunol 53: 53.","journal-title":"J Neuroimmunol"},{"key":"19_CR35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0162-3109(95)00033-6","volume":"31","author":"DJJ Carr","year":"1995","unstructured":"Carr, D. J. J. and M. Serou. 1995. Exogenous and endogenous opioids as biological response modifiers. Immunopharmacology 31: 59.","journal-title":"Immunopharmacology"},{"key":"19_CR36","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0006-2952(93)90508-T","volume":"46","author":"PK Peterson","year":"1993","unstructured":"Peterson, P. K., T. W. Molitor, and C. C. Chao. 1993. Mechanisms of morphine-induced immunomodulation. Biochem Pharmacol 46: 343.","journal-title":"Biochem Pharmacol"},{"key":"19_CR37","first-page":"161","volume":"59","author":"RJ Weber","year":"1997","unstructured":"Weber, R. J., P. K. Mishra, J.-L. Suo, and D. Hall. 1997. Elevated splenic catecholamines and immunosuppression following microinjection of morphine into the PAG. College for the Problems of Drug Dependence Submitted 59: 161. (Abstract)","journal-title":"College for the Problems of Drug Dependence Submitted"},{"key":"19_CR38","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/0024-3205(96)00066-5","volume":"58","author":"TG Dinan","year":"1996","unstructured":"Dinan, T. G. 1996. Serotonin and the regulation of hypothalamic-pituitary-adrenal axis function. Life Sci 58: 1683.","journal-title":"Life Sci"},{"key":"19_CR39","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/BF00489545","volume":"86","author":"Z Liposits","year":"1987","unstructured":"Liposits, Z., C. Phelix, and W. K. Pauli. 1987. Synaptic interaction of serotonergic axons and corticotropin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. A light and electron microscopic immunocytochemical study. Histochemistry 86: 541.","journal-title":"Histochemistry"},{"key":"19_CR40","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S0022-3565(25)38360-6","volume":"266","author":"KE Barke","year":"1993","unstructured":"Barke, K. E. and L. B. Hough. 1993. Simultaneous measurement of opiate-induced histamine release in the periaqueductal gray and opiate antinociception\u2014an in vivo microdialysis study. J Pharmacol Exp Ther 266: 934.","journal-title":"J Pharmacol Exp Ther"},{"key":"19_CR41","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/978-1-4615-1951-5_19","volume":"373","author":"DT Lysle","year":"1995","unstructured":"Lysle, D. T., K. Fecho, K. A. Maslonek, and L. A. Dykstra. 1995. Evidence for the involvement of macro-phage-derived nitric oxide in the immunomodulatory effect of morphine and aversive Pavlovian conditioning. Adv. Exp. Med. Biol. 373: 141.","journal-title":"Adv. Exp. Med. Biol."}],"container-title":["Advances in Experimental Medicine and Biology","Drugs of Abuse, Immunomodulation, and Aids"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4615-5347-2_19.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T15:36:46Z","timestamp":1741448206000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4615-5347-2_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998]]},"ISBN":["9781461374398","9781461553472"],"references-count":41,"URL":"https:\/\/doi.org\/10.1007\/978-1-4615-5347-2_19","relation":{},"ISSN":["0065-2598"],"issn-type":[{"type":"print","value":"0065-2598"}],"subject":[],"published":{"date-parts":[[1998]]}}}